Dr. Carlene MacMillan

Dr. Carlene MacMillan is a dual board-certified child, adolescent, and adult psychiatrist who serves as Radial's Chief Product Officer. She focuses on building robust technology infrastructure and advocating for improved insurance coverage to expand access to breakthrough psychiatric treatments.Dr. MacMillan previously served as Chief Medical Officer at Osmind, an electronic health record company, and currently advises multiple healthtech and medical device companies. She earned both her undergraduate and medical degrees from Harvard University, followed by residency and fellowship training at Harvard's MGH/McLean Hospital.She actively contributes to the advancement of interventional psychiatry through participation in prospective and post-marketing research for transcranial magnetic stimulation, esketamine and other novel interventions. She is a Member-at-Large on the Executive Committee and Co-Chair of the Insurance Committee for the Clinical TMS Society, a Board Member of the Foundation for the Advancement of Clinical TMS, Co-Chair of the Public Resource Committee for the American Academy of Child and Adolescent Psychiatry, and Vice President of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage.Beyond her work in interventional psychiatry, Dr. MacMillan has extensive training in Mentalization Based Treatment, which she applies across individual therapy, group therapy, family therapy, and team/systems settings.